Serum cytokine and chemokine profiles in patients with myasthenia gravis
- 9 April 2014
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 176 (2) , 232-237
Abstract
Summary: Myasthenia gravis (MG) is an autoimmune-mediated inflammatory disease of the neuromuscular junction. Previous studies of animal MG models have suggested important roles of cytokines in MG pathogenesis, but adequate studies on cytokines in human MG are lacking. Using a multiplex suspension array system, we measured the serum levels of 27 cytokines/chemokines in 47 anti-acetylcholine receptor antibody-positive patients with MG and 20 normal controls (NC) to investigate the contribution of cytokines/chemokines toward MG pathogenesis. Correlations between clinical parameters and cytokine/chemokine levels in patients with MG were also examined. The serum levels of interleukin (IL)-15 (mean ± standard deviation: 6·85 ± 6·97 pg/ml) and vascular endothelial growth factor (VEGF) (96·21 ± 71·60 pg/ml) significantly increased, whereas IL-4 levels (3·57 ± 0·86 pg/ml) decreased in patients with MG compared with NC (IL-15: 4·42 ± 1·55 pg/ml; VEGF: 63·51 ± 32·95 pg/ml; IL-4: 4·15 ± 0·81 pg/ml, P < 0·05). In addition, eight cytokines (IL-4, IL-8, IL-15, eotaxin, macrophage inflammatory protein-1α, macrophage inflammatory protein-1β, VEGF and IL-1b) were significantly changed among MG patients with thymoma, MG patients without thymoma and NC (P < 0·05). Some cytokines, such as IL-4, IL-15, and VEGF, may play roles in the pathogenesis of MG.Keywords
Funding Information
- Ministry of Education, Science, and Technology
This publication has 22 references indexed in Scilit:
- Increased serum interleukin‐17 levels in patients with myasthenia gravisMuscle & Nerve, 2011
- T-cell Subset Regulation in AtopyCurrent Allergy and Asthma Reports, 2011
- Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6Multiple Sclerosis Journal, 2010
- CCL21 overexpressed on lymphatic vessels drives thymic hyperplasia in myastheniaAnnals of Neurology, 2009
- IL-4 receptor as a bridge between the immune system and muscle in experimental myasthenia gravis IClinical Immunology, 2009
- Neoplastic transformation and angiogenesis in the thymus of transgenic mice expressing SV40 T and t antigen under an l‐pyruvate kinase promoter (SV12 mice)International Journal of Experimental Pathology, 2005
- Dendritic cell‐derived IL‐15 controls the induction of CD8 T cell immune responsesEuropean Journal of Immunology, 2003
- THE IL-4 RECEPTOR: Signaling Mechanisms and Biologic FunctionsAnnual Review of Immunology, 1999
- A pathogenetic role for the thymoma in myasthenia gravis. Autosensitization of IL-4- producing T cell clones recognizing extracellular acetylcholine receptor epitopes presented by minority class II isotypes.Journal of Clinical Investigation, 1998
- Myasthenia GravisNew England Journal of Medicine, 1994